Compile Data Set for Download or QSAR
Report error Found 77 Enz. Inhib. hit(s) with all data for entry = 13379
Target5'-nucleotidase [27-547](Human)
AdoRx Therapeutics

US Patent
LigandPNGBDBM784634(5-[4-[3-[2-(1-Piperidyl)ethoxy]pyrrolidin-1-yl]thi...)
Affinity DataIC50: 11.1nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target5'-nucleotidase [27-547](Human)
AdoRx Therapeutics

US Patent
LigandPNGBDBM784708(5-[7-chloro-4-(7,7-difluoro-5-azaspiro[2.4]heptan-...)
Affinity DataIC50: 15nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target5'-nucleotidase [27-547](Human)
AdoRx Therapeutics

US Patent
LigandPNGBDBM784696(5-[7-chloro-4-(3,3-difluoro-4,4-dimethyl-pyrrolidi...)
Affinity DataIC50: 16nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target5'-nucleotidase [27-547](Human)
AdoRx Therapeutics

US Patent
LigandPNGBDBM784709(5-[7-chloro-4-(8,8-difluoro-6-azaspiro[3.4]octan-6...)
Affinity DataIC50: 20nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target5'-nucleotidase [27-547](Human)
AdoRx Therapeutics

US Patent
LigandPNGBDBM784648(5-[4-[3-[2-(1-Piperidyl)ethoxy]pyrrolidin-1-yl]thi...)
Affinity DataIC50: 20.1nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target5'-nucleotidase [27-547](Human)
AdoRx Therapeutics

US Patent
LigandPNGBDBM784650(5-[4-[3-[2-(1-Piperidyl)ethoxy]pyrrolidin-1-yl]pyr...)
Affinity DataIC50: 20.7nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target5'-nucleotidase [27-547](Human)
AdoRx Therapeutics

US Patent
LigandPNGBDBM784712(5-[4-(3,3-difluoro-4,4-dimethyl-pyrrolidin-1-yl)py...)
Affinity DataIC50: 20.8nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target5'-nucleotidase [27-547](Human)
AdoRx Therapeutics

US Patent
LigandPNGBDBM784646(5-[4-[3-[2-(1-Piperidyl)ethoxy]pyrrolidin-1-yl]fur...)
Affinity DataIC50: 22.8nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target5'-nucleotidase [27-547](Human)
AdoRx Therapeutics

US Patent
LigandPNGBDBM784699(5-[4-(8,8-difluoro-6-azaspiro[3.4]octan-6-yl)-7-fl...)
Affinity DataIC50: 22.9nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target5'-nucleotidase [27-547](Human)
AdoRx Therapeutics

US Patent
LigandPNGBDBM784647(5-[4-(3,3-Difluoro-4,4-dimethyl-pyrrolidin-1-yl)fu...)
Affinity DataIC50: 25.4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target5'-nucleotidase [27-547](Human)
AdoRx Therapeutics

US Patent
LigandPNGBDBM784707(5-[7-chloro-4-(3,3-difluoro-4,4-dimethyl-pyrrolidi...)
Affinity DataIC50: 29.3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target5'-nucleotidase [27-547](Human)
AdoRx Therapeutics

US Patent
LigandPNGBDBM784661(5-[4-(3,3-Dimethylpyrrolidin-1-yl)pyrazolo[3,4-d]p...)
Affinity DataIC50: 31.1nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target5'-nucleotidase [27-547](Human)
AdoRx Therapeutics

US Patent
LigandPNGBDBM784643(5-[4-[3,3-Difluoro-4-[2-(1-piperidyl)ethoxy]pyrrol...)
Affinity DataIC50: 32nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target5'-nucleotidase [27-547](Human)
AdoRx Therapeutics

US Patent
LigandPNGBDBM784654(5-[4-[3-[2-(1-Piperidyl)ethoxy]pyrrolidin-1-yl]pyr...)
Affinity DataIC50: 33.7nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target5'-nucleotidase [27-547](Human)
AdoRx Therapeutics

US Patent
LigandPNGBDBM784688(5-[4-(3,3-Difluoro-4,4-dimethyl-pyrrolidin-1-yl)py...)
Affinity DataIC50: 34.2nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target5'-nucleotidase [27-547](Human)
AdoRx Therapeutics

US Patent
LigandPNGBDBM784701(5-[4-(3,3-difluoro-4-hydroxy-pyrrolidin-1-yl)-7-fl...)
Affinity DataIC50: 35.1nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target5'-nucleotidase [27-547](Human)
AdoRx Therapeutics

US Patent
LigandPNGBDBM784687(6-[1-[2-(2,4-Dioxo-1H-pyrimidin-5-yl)pyrazolo[3,4-...)
Affinity DataIC50: 35.5nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target5'-nucleotidase [27-547](Human)
AdoRx Therapeutics

US Patent
LigandPNGBDBM784656(5-[4-(7,7-Difluoro-5-azaspiro[2.4]heptan-5-yl)pyra...)
Affinity DataIC50: 37.1nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target5'-nucleotidase [27-547](Human)
AdoRx Therapeutics

US Patent
LigandPNGBDBM784689(5-[4-(8,8-Difluoro-6-azaspiro[3.4]octan-6-yl)pyraz...)
Affinity DataIC50: 42.3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target5'-nucleotidase [27-547](Human)
AdoRx Therapeutics

US Patent
LigandPNGBDBM784700(5-[4-(3,3-difluoro-4-methoxy-pyrrolidin-1-yl)-7-fl...)
Affinity DataIC50: 43.3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target5'-nucleotidase [27-547](Human)
AdoRx Therapeutics

US Patent
LigandPNGBDBM784655(5-[4-(3,3-Difluoro-4,4-dimethyl-pyrrolidin-1-yl)py...)
Affinity DataIC50: 44.8nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target5'-nucleotidase [27-547](Human)
AdoRx Therapeutics

US Patent
LigandPNGBDBM784704(5-[4-(7,7-difluoro-5-azaspiro[2.4]heptan-5-yl)-7-f...)
Affinity DataIC50: 46nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target5'-nucleotidase [27-547](Human)
AdoRx Therapeutics

US Patent
LigandPNGBDBM784663(5-[4-(3,3,4,4-Tetrafluoropyrrolidin-1-yl)pyrazolo[...)
Affinity DataIC50: 47.6nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target5'-nucleotidase [27-547](Human)
AdoRx Therapeutics

US Patent
LigandPNGBDBM784669(5-[4-(3,3-Difluoro-4-methoxy-pyrrolidin-1-yl)pyraz...)
Affinity DataIC50: 49.2nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target5'-nucleotidase [27-547](Human)
AdoRx Therapeutics

US Patent
LigandPNGBDBM784710(4-(3,3-difluoro-4,4-dimethyl-pyrrolidin-1-yl)-2-(2...)
Affinity DataIC50: 52nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target5'-nucleotidase [27-547](Human)
AdoRx Therapeutics

US Patent
LigandPNGBDBM784691(5-[4-(3,3-difluoro-4-methoxy-pyrrolidin-1-yl)pyraz...)
Affinity DataIC50: 54.7nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target5'-nucleotidase [27-547](Human)
AdoRx Therapeutics

US Patent
LigandPNGBDBM784698(5-[4-(3,3-Difluoro-4,4-dimethyl-pyrrolidin-1-yl)-7...)
Affinity DataIC50: 55.6nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target5'-nucleotidase [27-547](Human)
AdoRx Therapeutics

US Patent
LigandPNGBDBM784644(5-[7-[3-[2-(1-Piperidyl)ethoxy]pyrrolidin-1-yl]thi...)
Affinity DataIC50: 57.3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target5'-nucleotidase [27-547](Human)
AdoRx Therapeutics

US Patent
LigandPNGBDBM784697(5-[4-(3,3-difluoro-4,4-dimethyl-pyrrolidin-1-yl)-7...)
Affinity DataIC50: 58nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target5'-nucleotidase [27-547](Human)
AdoRx Therapeutics

US Patent
LigandPNGBDBM784677(5-[4-(8,8-Difluoro-6-azaspiro[3.4]octan-6-yl)furo[...)
Affinity DataIC50: 58.2nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target5'-nucleotidase [27-547](Human)
AdoRx Therapeutics

US Patent
LigandPNGBDBM784705(5-[4-[3,3-difluoro-4-[(4-methylmorpholin-2-yl)meth...)
Affinity DataIC50: 59nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target5'-nucleotidase [27-547](Human)
AdoRx Therapeutics

US Patent
LigandPNGBDBM784674(5-[4-[3,3-Difluoro-4-[2-(1-piperidyl)ethoxy]pyrrol...)
Affinity DataIC50: 59.4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target5'-nucleotidase [27-547](Human)
AdoRx Therapeutics

US Patent
LigandPNGBDBM784637(6-[1-[6-(2,4-Dioxo-1H-pyrimidin-5-yl)thieno[2,3-d]...)
Affinity DataIC50: 59.6nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target5'-nucleotidase [27-547](Human)
AdoRx Therapeutics

US Patent
LigandPNGBDBM784657(5-[4-(8,8-Difluoro-6-azaspiro[3.4]octan-6-yl)pyraz...)
Affinity DataIC50: 60.7nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target5'-nucleotidase [27-547](Human)
AdoRx Therapeutics

US Patent
LigandPNGBDBM784676(5-[2-Chloro-4-[3-[2-(1-piperidyl)ethoxy]pyrrolidin...)
Affinity DataIC50: 62.5nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target5'-nucleotidase [27-547](Human)
AdoRx Therapeutics

US Patent
LigandPNGBDBM784670(5-[4-[3-[2-(1-Piperidyl)ethoxy]pyrrolidin-1-yl]thi...)
Affinity DataIC50: 62.8nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target5'-nucleotidase [27-547](Human)
AdoRx Therapeutics

US Patent
LigandPNGBDBM784706(5-[4-(3,3-Difluoro-4,4-dimethyl-pyrrolidin-1-yl)py...)
Affinity DataIC50: 65nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target5'-nucleotidase [27-547](Human)
AdoRx Therapeutics

US Patent
LigandPNGBDBM784702(5-[7-fluoro-4-(2-oxa-7-azaspiro[3.4]octan-7-yl)pyr...)
Affinity DataIC50: 68.2nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target5'-nucleotidase [27-547](Human)
AdoRx Therapeutics

US Patent
LigandPNGBDBM784693(5-[4-(3,3-difluoro-4-hydroxy-pyrrolidin-1-yl)pyraz...)
Affinity DataIC50: 71.9nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target5'-nucleotidase [27-547](Human)
AdoRx Therapeutics

US Patent
LigandPNGBDBM784662(5-[4-(3,3-Diethylpyrrolidin-1-yl)pyrazolo[3,4-d]py...)
Affinity DataIC50: 73.9nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target5'-nucleotidase [27-547](Human)
AdoRx Therapeutics

US Patent
LigandPNGBDBM784642(5-[4-[3-[(4-Methylmorpholin-2-yl)methoxy]pyrrolidi...)
Affinity DataIC50: 74.3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target5'-nucleotidase [27-547](Human)
AdoRx Therapeutics

US Patent
LigandPNGBDBM784690(5-[4-(7,7-Difluoro-5-azaspiro[2.4]heptan-5-yl)pyra...)
Affinity DataIC50: 83.7nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target5'-nucleotidase [27-547](Human)
AdoRx Therapeutics

US Patent
LigandPNGBDBM784660(5-[4-(3-Ethyl-3-methyl-pyrrolidin-1-yl)pyrazolo[3,...)
Affinity DataIC50: 84.7nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target5'-nucleotidase [27-547](Human)
AdoRx Therapeutics

US Patent
LigandPNGBDBM784651(5-[4-[3-[2-(4,4-Difluoro-1-piperidyl)ethoxy]pyrrol...)
Affinity DataIC50: 85.4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target5'-nucleotidase [27-547](Human)
AdoRx Therapeutics

US Patent
LigandPNGBDBM784638(5-[4-(3,3-Difluoro-4,4-dimethyl-pyrrolidin-1-yl)th...)
Affinity DataIC50: 87.3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target5'-nucleotidase [27-547](Human)
AdoRx Therapeutics

US Patent
LigandPNGBDBM784645(5-[7-(3,3-difluoro-4,4-dimethyl-pyrrolidin-1-yl)th...)
Affinity DataIC50: 94nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target5'-nucleotidase [27-547](Human)
AdoRx Therapeutics

US Patent
LigandPNGBDBM784659(5-[4-[(3aR,6aS)-3,3a,4,5,6,6a-Hexahydro-1H-cyclope...)
Affinity DataIC50: 95nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target5'-nucleotidase [27-547](Human)
AdoRx Therapeutics

US Patent
LigandPNGBDBM784639(5-[4-[3-(2-pyridylmethoxy)pyrrolidine-1-yl]thieno[...)
Affinity DataIC50: 96nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target5'-nucleotidase [27-547](Human)
AdoRx Therapeutics

US Patent
LigandPNGBDBM784678(5-[4-(4,4-Difluoro-2-azaspiro[4.4]nonan-2-yl)furo[...)
Affinity DataIC50: 96.2nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Target5'-nucleotidase [27-547](Human)
AdoRx Therapeutics

US Patent
LigandPNGBDBM784694(5-[4-[3,3-difluoro-4-[(4-methylmorpholin-2-yl)meth...)
Affinity DataIC50: 99nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
2/25/2026
Entry Details US Patent

Displayed 1 to 50 (of 77 total ) | Next | Last >>
Jump to: